An Open-Label, Randomized Study of Recurrent Hepatitis C Post-Liver Transplant with Prograf® to Neoral® Conversion and C2 Monitoring - An Investigator Initiated Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date10/21/021/1/11

Funding

  • Novartis Pharmaceuticals Corporation (Agmt 2/22/05)